Remove 2019 Remove Documentation Remove Medical Records
article thumbnail

Antimicrobial Choice

RX Note

Often, to find a quick answer for the antibiotic for a certain infectious disease, I will look up National Antimicrobial Guideline, 2019 or Sanford Guide to Antimicrobial Therapy. Example of patients with altered pharmacokinetics (e.g. before the availability of culture or susceptibility testing result).

article thumbnail

Long-Awaited Guidance on FDAMA 115: Confirmatory Evidence Finally Has Its Moment (to be Crossed Off the FDA’s Guidance To-Do List)

FDA Law Blog: Biosimilars

The new guidance is one of three policy documents dedicated to explaining FDA’s interpretation of this statutory authority and their approach to exercising scientific judgment in evaluating drug effectiveness. We are heartened to see that this latest guidance reflects many of the advances we observed in practice since 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

This guidance, when finalized, will replace the original version of this document finalized in 2017. Based on a review of premarket submissions made in 2012 through 2019, FDA identified 90 examples of 510(k)s, De Novos, HDEs, and PMAs approved/cleared which utilized RWE in support of regulatory decision-making.

article thumbnail

Anas Batikhi, Founder & CEO at Santechture Shares on RCM-Tech, A Necessity in The Healthcare Industry

PharmaShots

Coding errors will most likely lead to n claim denials and delayed payments if medical necessity is not correctly represented or coding guidelines and best practices were not followed. THYNK assists in patient eligibility & pre-approval checks adding to it medical necessity & documentation checks.

article thumbnail

The case for AI and machine learning in life sciences

Pharmaceutical Technology

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. Consent documents often describe technical medical conditions and regulatory bodies are increasing pressure on sponsors to ensure that patient-facing information can be easily understood by patients.